Tag: clinical trials

Quality Control and Peer Review Processes for High-Stakes Safety Management Plan & Unblinding Procedures Quality Control and Peer Review Processes for High-Stakes Safety Management Plan & Unblinding Procedures In the context of clinical trials, particularly within organizations like Sanofi, maintaining rigorous quality control and robust peer review processes is imperative for ensuring the effectiveness of…

Read More “Quality Control and Peer Review Processes for High-Stakes Safety Management Plan & Unblinding Procedures” »

Safety Management Plan & Unblinding Procedures for Oncology, Rare Disease and High-Risk Therapeutic Areas Safety Management Plan & Unblinding Procedures for Oncology, Rare Disease and High-Risk Therapeutic Areas In the realm of clinical studies, particularly in oncology, rare diseases, and high-risk therapeutic areas, the integrity of safety management is paramount. A robust safety management plan…

Read More “Safety Management Plan & Unblinding Procedures for Oncology, Rare Disease and High-Risk Therapeutic Areas” »

Vendor and Partner Oversight Considerations Related to Safety Management Plan & Unblinding Procedures Vendor and Partner Oversight Considerations Related to Safety Management Plan & Unblinding Procedures In the evolving landscape of clinical trials, particularly in the context of global studies such as world wide clinical trials, the effective oversight of vendors and partners has become…

Read More “Vendor and Partner Oversight Considerations Related to Safety Management Plan & Unblinding Procedures” »

Metrics and KPIs to Monitor the Quality and Timeliness of Safety Management Plan & Unblinding Procedures In clinical trial centers, it is essential to maintain a rigorous approach to safety management and unblinding procedures. The complexities surrounding these processes require a clear understanding of metrics and key performance indicators (KPIs) that demonstrate compliance while upholding…

Read More “Metrics and KPIs to Monitor the Quality and Timeliness of Safety Management Plan & Unblinding Procedures” »

Case Studies: Safety Management Plan & Unblinding Procedures That Improved Approvals and Inspection Outcomes Case Studies: Safety Management Plan & Unblinding Procedures That Improved Approvals and Inspection Outcomes In the realm of clinical trials, the effective management of safety and unblinding procedures is paramount to ensuring not only regulatory compliance but also the integrity of…

Read More “Case Studies: Safety Management Plan & Unblinding Procedures That Improved Approvals and Inspection Outcomes” »

Common Deficiencies in Safety Management Plan & Unblinding Procedures Highlighted in FDA, EMA and MHRA Inspections Common Deficiencies in Safety Management Plan & Unblinding Procedures Highlighted in FDA, EMA and MHRA Inspections Introduction to Safety Management Plans in Clinical Trials A Safety Management Plan (SMP) is essential for the successful conduct of clinical trials. It…

Read More “Common Deficiencies in Safety Management Plan & Unblinding Procedures Highlighted in FDA, EMA and MHRA Inspections” »

Aligning Safety Management Plan & Unblinding Procedures With Protocol, SAP and Risk Management Frameworks Aligning Safety Management Plan & Unblinding Procedures With Protocol, SAP and Risk Management Frameworks The alignment of the Safety Management Plan (SMP) and unblinding procedures with the study protocol, Statistical Analysis Plan (SAP), and overall risk management frameworks is crucial in…

Read More “Aligning Safety Management Plan & Unblinding Procedures With Protocol, SAP and Risk Management Frameworks” »

Digital-First Safety Management Plan & Unblinding Procedures Strategies for Complex and Decentralized Trials Digital-First Safety Management Plan & Unblinding Procedures Strategies for Complex and Decentralized Trials In the evolving landscape of clinical trials, particularly within the settings of complex and decentralized studies, the need for robust safety management plans and efficient unblinding procedures cannot be…

Read More “Digital-First Safety Management Plan & Unblinding Procedures Strategies for Complex and Decentralized Trials” »

Templates, Checklists and Governance Models for Robust Safety Management Plan & Unblinding Procedures Templates, Checklists and Governance Models for Robust Safety Management Plan & Unblinding Procedures Clinical trials are a crucial element in the drug development process, especially for biosimilar clinical trials. Ensuring safety and maintaining the integrity of study participants are paramount. As such,…

Read More “Templates, Checklists and Governance Models for Robust Safety Management Plan & Unblinding Procedures” »

Using Safety Management Plan & Unblinding Procedures to Strengthen Submission Packages and Health Authority Reviews Using Safety Management Plan & Unblinding Procedures to Strengthen Submission Packages and Health Authority Reviews Introduction to Safety Management Plans in Clinical Trials The implementation of a Safety Management Plan (SMP) is critical in the context of til therapy clinical…

Read More “Using Safety Management Plan & Unblinding Procedures to Strengthen Submission Packages and Health Authority Reviews” »